Skip to main content
Premium Trial:

Request an Annual Quote

Planning, Precision, and Profit Margins

Holly at From Bench to Business highlights four questions any scientist-entrepreneur should ask themselves before beginning their own bio-business. First and foremost, she writes, those looking to make their science profitable should be prepared for the possibility of failure; sure, scientists are used to "little failures" on a day-to-day basis at the bench, but "I am asking how you would react to something you worked for a year on, for 14 hours a day, seven days a week?" Second, how would you handle a shift in focus away from science? "Many scientists I know are research purists," Holly writes, adding "if the project has to be changed in the name of profit, some would feel like they are 'selling out.'" Next, bio-business entrepreneurs must be willing to "create everything from scratch," including a flexible business plan covering all bases from human resources to sales to accounting, management, and customer service. Finally, scientists looking to break into business must be reasonable about their expectations: "The average business takes five years to become profitable," she notes.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.